SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of Kayak Software Corporation (KYAK), First California Financial Group, Inc. (FCAL), Metropolitan Health Networks, Inc. (MDF) and DUSA Pharmaceuticals Inc. (DUSA)

NEW YORK, Nov. 9, 2012 /PRNewswire/ --

Kayak Software Corporation
Levi & Korsinsky is investigating the Board of Directors of Kayak Software Corporation (NasdaqGS: KYAK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to priceline.com Incorporated (NasdaqGS: PCLN) under which shareholders would receive cash and stock valued at approximately $40 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/kayak-software-kyak, or call: 877-363-5972.

First California Financial Group, Inc.
Levi & Korsinsky is investigating the Board of Directors of First California Financial Group, Inc. (Nasdaq: FCAL) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to PacWest Bancorp (Nasdaq: PACW) for stock valued at approximately $8 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/first-california-financial-fcal, or call: 877-363-5972.

Metropolitan Health Networks, Inc.
Levi & Korsinsky is investigating the Board of Directors of Metropolitan Health Networks, Inc. (NYSE: MDF) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Humana Inc. (NYSE: HUM) for $11.25 per share. At least one analyst set a price target for Metropolitan stock at $13.00 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/metropolitan-health-networks-mdf, or call: 877-363-5972.

DUSA Pharmaceuticals Inc.
Levi & Korsinsky is investigating the Board of Directors of DUSA Pharmaceuticals Inc. (Nasdaq: DUSA) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Sun Pharmaceutical Industries Limited (Reuters: SUN.BO) for $8 per share.

Click here to learn more about the investigation: http://zlk.9nl.com/dusa-pharmaceuticals-dusa, or call: 877-363-5972.

Levi & Korsinsky is a national firm with offices in New York and Washington D.C.  The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits.  Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

SOURCE Levi & Korsinsky, LLP

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here